IDEAS home Printed from https://ideas.repec.org/r/taf/bushst/v57y2015i5p664-687.html
   My bibliography  Save this item

The evolution of the pharmaceutical industry

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Dosi, Giovanni & Palagi, Elisa & Roventini, Andrea & Russo, Emanuele, 2023. "Do patents really foster innovation in the pharmaceutical sector? Results from an evolutionary, agent-based model," Journal of Economic Behavior & Organization, Elsevier, vol. 212(C), pages 564-589.
  2. Daniel P. Gross & Bhaven N. Sampat, 2022. "Crisis Innovation Policy from World War II to COVID-19," Entrepreneurship and Innovation Policy and the Economy, University of Chicago Press, vol. 1(1), pages 135-181.
  3. Nuvolari, Alessandro & Russo, Emanuele, 2019. "Technical progress and structural change: a long-term view," MERIT Working Papers 2019-022, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  4. Stacciarini, João Henrique Santana, 2025. "Investigación y Desarrollo (I+D) en el Sector Farmacéutico: avances, limitaciones, selectividad y negligencia," SocArXiv vbxzs, Center for Open Science.
  5. Agustí Segarra‐Blasco & Mercedes Teruel & Sebastiano Cattaruzzo, 2024. "The international trade in human vaccines before COVID‐19," The World Economy, Wiley Blackwell, vol. 47(5), pages 1978-2008, May.
  6. Wu, Qiang & He, Qile, 2020. "DIY Laboratories and business innovation ecosystems: The case of pharmaceutical industry," Technological Forecasting and Social Change, Elsevier, vol. 161(C).
  7. Angelo Kenneth S. Romasanta & Peter Sijde & Jacqueline Muijlwijk-Koezen, 2020. "Innovation in pharmaceutical R&D: mapping the research landscape," Scientometrics, Springer;Akadémiai Kiadó, vol. 125(3), pages 1801-1832, December.
  8. Massimo Florio & Simona Gamba, 2021. "Biomed Europa: After the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," Annals of Public and Cooperative Economics, Wiley Blackwell, vol. 92(3), pages 387-409, September.
  9. Larissa Shnayder & Frank J. Van Rijnsoever, 2018. "How expected outcomes, stakeholders, and institutions influence corporate social responsibility at different levels of large basic needs firms," Business Strategy and the Environment, Wiley Blackwell, vol. 27(8), pages 1689-1707, December.
  10. Camille Loir & Bertrand Groslambert, 2023. "The impact of innovation on the profitability of the biotech industry," Economics Bulletin, AccessEcon, vol. 43(3), pages 1286-1297.
  11. Stacciarini, João Henrique Santana, 2025. "The Global Pharmaceutical Sector: numbers and dynamics," SocArXiv hbs8j, Center for Open Science.
  12. Fukuyama, Hirofumi & Matousek, Roman & Tzeremes, Nickolaos G., 2023. "Estimating the degree of firms’ input market power via data envelopment analysis: Evidence from the global biotechnology and pharmaceutical industry," European Journal of Operational Research, Elsevier, vol. 305(2), pages 946-960.
  13. Hao Tan, 2017. "Making impact through industry-focused research: An Asia Pacific perspective," Asia Pacific Journal of Management, Springer, vol. 34(3), pages 487-503, September.
  14. Juha‐Antti Lamberg & Mirva Peltoniemi, 2020. "The nanoeconomics of firm‐level decision‐making and industry evolution: Evidence from 200 years of paper and pulp making," Strategic Management Journal, Wiley Blackwell, vol. 41(3), pages 499-529, March.
  15. Alexander S. Kritikos & Alexander Schiersch & Caroline Stiel, 2022. "The productivity shock in business services," Small Business Economics, Springer, vol. 59(3), pages 1273-1299, October.
  16. Pooja Thakur-Wernz & Olga Bruyaka, 2017. "Co-evolutionary Perspective on Sourcing Portfolios: Examining Sourcing Choices for Clinical Trials of Bio-pharmaceutical Firms," Management International Review, Springer, vol. 57(6), pages 909-946, December.
  17. Zoltán Lakner & Anna Kiss & József Popp & Zoltán Zéman & Domicián Máté & Judit Oláh, 2019. "From Basic Research to Competitiveness: An Econometric Analysis of the Global Pharmaceutical Sector," Sustainability, MDPI, vol. 11(11), pages 1-17, June.
  18. repec:ehu:cuader:49122 is not listed on IDEAS
  19. Ute Laermann-Nguyen & Martin Backfisch, 2021. "Innovation crisis in the pharmaceutical industry? A survey," SN Business & Economics, Springer, vol. 1(12), pages 1-37, December.
  20. Changhyeon Song & Kwangsoo Shin, 2019. "Business Model Design for Latecomers in Biopharmaceutical Industry: The Case of Korean Firms," Sustainability, MDPI, vol. 11(18), pages 1-15, September.
  21. Patricia Laurens & Christian Le Bas & Antoine Schoen, 2019. "Worldwide IP coverage of patented inventions in large pharma firms: to what extent do the internationalisation of R&D and firm strategy matter?," Post-Print hal-01725229, HAL.
  22. Rosiello, Alessandro & Maleki, Ali, 2021. "A dynamic multi-sector analysis of technological catch-up: The impact of technology cycle times, knowledge base complexity and variety," Research Policy, Elsevier, vol. 50(3).
  23. Busfield, Joan, 2020. "Documenting the financialisation of the pharmaceutical industry," Social Science & Medicine, Elsevier, vol. 258(C).
  24. Miozza, Mario & Brunetta, Federica & Appio, Francesco Paolo, 2024. "Digital transformation of the Pharmaceutical Industry: A future research agenda for management studies," Technological Forecasting and Social Change, Elsevier, vol. 207(C).
  25. Seung In Um & Changone Kim & Taejin Ha & Jinju Kim & Heesang Lee, 2022. "Morphological Change and Internal Growth Factors of Firms in the Korean Pharmaceutical Industry in Recent Decades," Sustainability, MDPI, vol. 14(22), pages 1-19, November.
  26. Mayimele, Nsovo & Demana, Patrick & Keele, Mothobi, 2023. "Perceptions of Board Members on the Presence of Pharmacists as Strategic Leaders of Manufacturing Pharmaceutical Companies Operating in South Africa: A Qualitative Study," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 7(2), pages 87-98.
  27. Boutillier, Sophie & Laperche, Blandine & Lebert, Didier & Elouaer-Mrizak, Sana, 2023. "A systemic analysis of the technological trajectory at company level based on patent data: The case of Sanofi's vaccine technology," Technovation, Elsevier, vol. 124(C).
  28. Gergő Tömöri & Vilmos Lakatos & Bernadett Béresné Mártha, 2021. "The Effect of Financial Risk Taking on Profitability in the Pharmaceutical Industry," Economies, MDPI, vol. 9(4), pages 1-14, October.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.